16th JPIAMR transnational call for research projects - AMR diagnostics and surveillance 2023 (DISTOMOS)


This is a match-making section for JPIAMR 16th call -AMR diagnostics and surveillance 2023 (DISTOMOS).

General Information

  • Type: Partner looking for project
  • Organisation: NG BIOTECH
  • Country: France (FR)
  • Career stage: Other.

Research area

  • Scientific area(s) of the call:
    1. Topic 1: to develop novel, or improve existing, diagnostics, including point of care diagnostics, that can rule out antimicrobial use or help identify the most effective antimicrobial treatment
  • One Health Setting:

    Human Health

    Animal Health (incl. wild-life, livestock, acquatic organisms, and companion animals)

  • Keywords:

    AMR DIAGNOSTICS RAPID TEST POC RESISTANCE GENES HUMAND & VETERINARY

  • Brief description of your expertise / expertise you are looking for:

    Created in France by pioneers in in vitro rapid diagnostic tests, NG Biotech has leveraged the Lateral Flow Immunochromatography (LFIA) to become a leading expert in the field of rapid tests for AMR and infectious diseases. NG Biotech has developed a range of Antimicrobial Resistance (AMR), rapid tests including the only multiplex LFIA test (NG-Test® CARBA-5) for the detection and differentiation of the five most prevalent carbapenemase families (KPC, OXA-48-like, VIM, IMP and NDM) and their most clinically relevant variants in less than 15 minutes in a single cassette. Our current product range includes tests to detect ESBL resistance (NG-Test® CTX-M MULTI) and Colistin resistance (NG-Test® MCR-1). With our renowned network, our rapid tests, fully developed and produced in France, are distributed worldwide in more than 70 countries and we have developed a proprietary patented immunoassay platform which can be tailored for your projects We are also an active member of the BEAM Alliance.

  • Brief description of your project / the project you would like to join:

    We are open to participate in any project where we can use our existing technology and improve our range of rapid tests for the detection of AMR genes/resistance, therefore supporting " help identify the most effective antimicrobial treatment”.

Contact details

Antonio Soares

Submitted on 2023-01-24 17:03:56

« Return to the partner search tool

Cookies

Partners